세계의 이식형 루프 레코더 시장 - 규모, 점유율, 동향 분석 보고서 : 활성화별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Implantable Loop Recorders Market Size, Share & Trends Analysis Report By Activation (Automatic, Manual), By Application (Atrial Fibrillation, Cardiac Arrhythmia), By End Use (Hospitals, Cardiac Centers), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

이식형 루프 레코더 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 이식형 루프 레코더 시장 규모는 2025년부터 2030년까지 연평균 복합 성장률(CAGR) 10.1%를 기록했으며, 2030년까지는 27억 7,000만 달러에 달한다고 예측됩니다.

심장 부정맥 발생률 증가, 무증상 실신, 심장 장치의 기술 진보가 시장을 견인하고 있습니다.

미국에서는 2018년에 8,570만명 이상이 스트레스가 많은 라이프스타일에 의한 고혈압이나 고혈압에 시달리고 있습니다. 성인 3명 중 1명은 신체 활동에 관한 현행 가이드라인을 충족하지 않습니다. 또한 2016년에는 미국 성인의 약 18.0%가 고비중 지단백 콜레스테롤치가 40mg/dl 미만이었습니다.

이식형 루프 레코더 시장 보고서 하이라이트 :

• 자동 레코더 부문은 2024년에 60.6%의 최대 시장 점유율을 차지하며 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 심방세동분야는 2024년에 41.8%의 최대 시장 점유율을 차지하며 예측기간 중에 10.9%의 연평균 복합 성장률(CAGR)로 가장 빠른 성장이 예상됩니다.
• 병원 부문은 2024년에 58.9%의 최대 시장 점유율을 차지했습니다.
• 북미의 이식형 루프 레코더 시장은 심혈관 질환의 유병률 증가와 고령화 인구 증가로 2024년 36.8%의 수익 점유율을 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 이식형 루프 레코더 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 이식형 루프 레코더 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 이식형 루프 레코더 시장 : 활성화 추정·동향 분석

• 세계의 이식형 루프 레코더 시장 : 액티베이션 대시보드
• 세계의 이식형 루프 레코더 시장 : 활성화 변동 분석
• 세계의 이식형 루프 레코더 시장 : 액티베이션별, 수익
• 자동 레코더
• 수동 레코더

제5장 이식형 루프 레코더 시장 : 용도의 추정·동향 분석

• 세계의 이식형 루프 레코더 시장 :용도 대시보드
• 세계의 이식형 루프 레코더 시장 : 용도 변동 분석
• 세계의 이식형 루프 레코더 시장 : 용도별, 수익
• 심방세동
• 부정맥
• 심장성 실신

제6장 이식형 루프 레코더 시장 : 최종 용도의 추정·동향 분석

• 세계의 이식형 루프 레코더 시장 : 최종 용도 대시보드
• 세계의 이식형 루프 레코더 시장 : 최종 용도 변동 분석
• 세계의 이식형 루프 레코더 시장 : 최종 용도별, 수익별
• 병원
• 심장센터
• 기타

제7장 이식형 루프 레코더 시장 : 지역 추정·동향 분석, 나라, 액티베이션, 용도, 최종 용도별

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년:
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 최근의 동향과 영향 분석, 주요 제조업체별
• 기업/경쟁의 분류
• 벤더 상황
  • 주요 리셀러와 채널 파트너 목록
  • 주요 고객
  • 주요 기업의 시장 점유율 분석, 2024년
• 기업 프로파일
  • Medtronic
  • Biotronik
  • Abbott
  • Angel Medical Systems, Inc
  • Boston Scientific Corporation
  • GE Healthcare
  • Koninklijke Philips NV
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Vectorious

JHS

영문 목차

영문목차

Implantable Loop Recorders Market Growth & Trends:

The global implantable loop recorders market size is expected to reach USD 2.77 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of cardiac arrhythmia, asymptomatic syncope and technological advancement in cardiac devices are driving the market.

More than 85.7 million people in U.S. suffer from high BP and hypertension due to stressful lifestyle in 2018. These factors are expected to increase the burden of CVDs in the country over the forecast period. Moreover, one in every three U.S. adults does not meet the current guidelines for physical activity. In addition, in 2016, about 18.0% of U.S. adults had high-density lipoprotein cholesterol levels of less than 40 mg/dl. The aforementioned factors require self-care management which is boosting the demand for implantable loop recorders.

Implantable Loop Recorders Market Report Highlights:

• The automatic recorders segment held the largest market share of 60.6% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
• The atrial fibrillation segment held the largest market share of 41.8% in 2024 and is expected to grow at the fastest CAGR of 10.9% during the forecast period.
• The hospitals segment held the largest market share of 58.9% in 2024. Hospitals are primary locations for the use of implantable loop recorders, where patients with suspected arrhythmias or unexplained heart issues are monitored.
• Implantable loop recorders market in North America dominated with a revenue share of 36.8% in 2024 due to the increasing prevalence of cardiovascular diseases and a rising aging population.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Activation
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Activation outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. Implantable Loop Recorders Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of cardiac conditions
    • 3.2.1.2. Technological advancements in implantable devices
    • 3.2.1.3. Demand for continuous, minimally invasive monitoring
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High procedure and device costs
    • 3.2.2.2. Risk of complications and malfunctions
• 3.3. Implantable Loop Recorders Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Implantable Loop Recorders Market: Activation Estimates & Trend Analysis

• 4.1. Global Implantable Loop Recorders Market: Activation Dashboard
• 4.2. Global Implantable Loop Recorders Market: Activation Movement Analysis
• 4.3. Global Implantable Loop Recorders Market by Activation, Revenue
• 4.4. Automatic Recorders
  • 4.4.1. Automatic recorders market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Manual Recorders
  • 4.5.1. Manual recorders market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Implantable Loop Recorders Market: Application Estimates & Trend Analysis

• 5.1. Global Implantable Loop Recorders Market: Application Dashboard
• 5.2. Global Implantable Loop Recorders Market: Application Movement Analysis
• 5.3. Global Implantable Loop Recorders Market by Application, Revenue
• 5.4. Atrial Fibrillation
  • 5.4.1. Atrial fibrillation market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.5. Cardiac Arrythmia
  • 5.5.1. Cardiac arrythmia market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.6. Cardiac Syncope
  • 5.6.1. Cardiac syncope market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Implantable Loop Recorders Market: End Use Estimates & Trend Analysis

• 6.1. Global Implantable Loop Recorders Market: End Use Dashboard
• 6.2. Global Implantable Loop Recorders Market: End Use Movement Analysis
• 6.3. Global Implantable Loop Recorders Market by End Use, Revenue
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.5. Cardiac Centers
  • 6.5.1. Cardiac centers market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Implantable Loop Recorders Market: Regional Estimates & Trend Analysis by Country, Activation, Application and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Medtronic
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Biotronik
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Abbott
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Angel Medical Systems, Inc
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Boston Scientific Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. GE Healthcare
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Koninklijke Philips N.V.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. MicroPort Scientific Corporation
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Nihon Kohden Corporation
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Vectorious
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives

관련자료